| # | Drug | Count |
|---|---|---|
| 0 | DALFAMPRIDINE | 687 |
| 1 | DIVALPROEX SODIUM | 312 |
| 2 | VEDOLIZUMAB | 246 |
| 3 | PREDNISONE | 191 |
| 4 | ARIPIPRAZOLE | 189 |
| 5 | SIMVASTATIN | 166 |
| 6 | ALBUTEROL SULFATE | 142 |
| 7 | MEPOLIZUMAB | 142 |
| 8 | ASPIRIN | 113 |
| 9 | DIGOXIN | 113 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLOPHEDIANOL HYDROCHLORIDE, DEXCHLORPHENIRAMINE MALEATE, AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.1250 |
| 1 | DESONIDE 0.05% | 1 | 0.1111 |
| 2 | L-TRYPTOPHAN | 5 | 0.0113 |
| 3 | SORBITOL | 6 | 0.0100 |
| 4 | DALFAMPRIDINE | 687 | 0.0096 |
| 5 | RILONACEPT | 10 | 0.0086 |
| 6 | CLEMASTINE FUMARATE | 10 | 0.0072 |
| 7 | ALUMINUM HYDROXIDE GEL | 1 | 0.0068 |
| 8 | DIVALPROEX SODIUM | 312 | 0.0067 |
| 9 | ALUMINUM CHLORIDE | 1 | 0.0066 |
| # | Drug class | Count |
|---|---|---|
| 0 | Potassium Channel Blocker [EPC] | 687 |
| 1 | Atypical Antipsychotic [EPC] | 317 |
| 2 | Corticosteroid [EPC] | 313 |
| 3 | Integrin Receptor Antagonist [EPC] | 249 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 243 |
| 5 | Benzodiazepine [EPC] | 242 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 199 |
| 7 | Proton Pump Inhibitor [EPC] | 146 |
| 8 | Interleukin-5 Antagonist [EPC] | 142 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 115 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 142 | 0.2064 |
| 1 | Potassium Channel Blocker [EPC] | 687 | 0.0096 |
| 2 | Serotonin-4 Receptor Agonist [EPC] | 5 | 0.0076 |
| 3 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 6 | 0.0029 |
| 5 | Integrin Receptor Antagonist [EPC] | 249 | 0.0029 |
| 6 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 87 | 0.0027 |
| 7 | Provitamin D2 Compound [EPC] | 75 | 0.0025 |
| 8 | Recombinant Human Deoxyribonuclease 1 [EPC] | 41 | 0.0021 |
| 9 | Dopamine-2 Receptor Antagonist [EPC] | 14 | 0.0018 |